Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRKAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HMGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ID4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VKORC1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC257152 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
RTKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM92A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRIMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on